Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP3 | Q9NY33 | 5/20 | 0.52 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.52 |
| ▸ | CTSB | P07858 | 2/20 | 0.52 |
| ▸ | DPP4 | P27487 | 2/20 | 0.52 |
| ▸ | BCHE | P06276 | 1/20 | 0.49 |
| ▸ | KRAS | P01116 | 1/20 | 0.48 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.47 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29666786 | 0.93 | DPP3 (0.59) | DPP3DPP4OPRM1OPRD1 | |
| SCHEMBL29794046 | 0.92 | CAPN1 (0.54) | DPP3CAPN1CTSB | |
| SCHEMBL29379873 | 0.91 | DPP4 (0.58) | DPP3DPP4BCHEKRASSOS1 | |
| SCHEMBL30051339 | 0.90 | DPP4 (0.58) | DPP3DPP4BCHEKRASSOS1 | |
| SCHEMBL30051839 | 0.90 | DPP4 (0.54) | DPP3CAPN1CTSBDPP4BCHE | |
| SCHEMBL29666760 | 0.89 | DPP3 (0.53) | DPP3CAPN1CTSBDPP4BCHE | |
| SCHEMBL29794102 | 0.88 | CAPN1 (0.56) | DPP3CAPN1CTSB | |
| SCHEMBL29794085 | 0.88 | CAPN1 (0.56) | DPP3CAPN1CTSB | |
| SCHEMBL34461871 | 0.88 | CAPN1 (0.55) | DPP3CAPN1CTSBBCHEOPRD1 | |
| SCHEMBL30051395 | 0.88 | DPP3 (0.59) | DPP3DPP4KRASSOS1OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250326791-A1 | Peptide-Based Drugs for I.N. Delivery to Brain | NATIONAL INSTITUTES OF HEALTH | 2025-10-23 | — | — | US | disclosed |
| US-12378285-B2 | Cyclic peptides and cyclic peptide conjugates for treating neurological disorders | FLORIDA ATLANTIC UNIVERSITY RESEARCH CORPORATION (US) | 2025-08-05 | — | — | US | disclosed |
| US-12187813-B2 | Methods of identifying opioid cyclic peptides | FLORIDA ATLANTIC UNIVERSITY BOARD OF TRUSTEES (US) | 2025-01-07 | — | — | US | disclosed |
| US-12129311-B2 | Cyclic peptide combinatorial libraries | FLORIDA ATLANTIC UNIVERSITY RESEARCH CORPORATION (US) | 2024-10-29 | — | — | US | disclosed |
| US-20240132543-A1 | CYCLIC PEPTIDE COMBINATORIAL LIBRARIES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-04-25 | — | — | US | disclosed |
| US-20230295226-A1 | CYCLIC PEPTIDES AND CYCLIC PEPTIDE CONJUGATES FOR TREATING NEUROLOGICAL DISORDERS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-09-21 | — | — | US | disclosed |
| US-20230257418-A1 | METHODS OF IDENTIFYING OPIOID CYCLIC PEPTIDES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-08-17 | — | — | US | disclosed |
| US-11578100-B2 | Cyclic peptides, cyclic peptide conjugates and methods of use thereof | FLORIDA ATLANTIC UNIVERSITY RESEARCH CORPORATION (US) | 2023-02-14 | — | — | US | disclosed |